Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment.

Zidovudine or 3'-azido-2'-3'-dideoxy-thymidine (AZT) is an antiviral drug widely used to treat HIV-infected patients. Because cytotoxic T lymphocytes (CTL) are thought to contribute actively to resistance against HIV-induced disease, we studied sequentially 10 HIV-infected individuals...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Dadaglio, G, Michel, F, Langlade-Demoyen, P, Sansonetti, P, Chevrier, D, Vuillier, F, Plata, F, Hoffenbach, A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 1992
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1554229/
https://ncbi.nlm.nih.gov/pubmed/1733639
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia